Michael May

Michael May, Board Chairman

Dr. Michael May is currently the Chief Executive Officer of the Centre for Commercialization of Regenerative Medicine (CCRM). Prior to CCRM, he was Co-Founder, President and Chief Operating Officer of Rimon Therapeutics Ltd., a Toronto-based regenerative medicine company developing novel medical polymers that possess drug-like activity. He sits on a number of Boards and advisory committees, including: MaRS Innovation, Rimon Therapeutics Ltd., 20/20 Vision, the Advanced Regenerative Tissue Engineering Centre, the Department of Chemical Engineering and Applied Chemistry at the University of Toronto, and the McMaster Mohawk Biotechnology Program. Dr. May completed his Ph.D. in Chemical Engineering at the University of Toronto as a National Sciences and Engineering Research Council of Canada Scholar and was awarded the Martin Walmsley Fellowship for Technological Entrepreneurship. michael.may@excellthera.ca